Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Preliminary trial of recombinant fibrolast interferon in chronic hepatitis B virus infection, Antimicrob Agents Chemother

Preliminary trial of recombinant fibrolast interferon in chronic hepatitis B virus infection, Antimicrob Agents Chemother. 1986; 29:122-6.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.